Reslizumab
Rx Item-Cinqair (Reslizumab) 10Mg/Ml Inj Sinle Use Vial 10Ml By Teva Respiratory
Brand name: Auvi-Q
Teva announces FDA approval for asthma injection, Cinqair | Pharmafile
NICE changes mind and backs new drug for severe asthma | Nursing Times
Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 Trials - The Journal of Allergy and Clinical Immunology: In Practice
A Guide to the Prescription and Service Request Form
cinqaero - Twitter Search / Twitter
New Severe Asthma Rx Gets Green Light | RxWiki
Anti–IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison - Journal of Allergy and Clinical Immunology
Teva's severe eosinophilic asthma drug Cinqaero wins EU approval
Injectable asthma drug reslizumab approved by European Commission - The Pharmaceutical Journal
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study - The Journal of Allergy and Clinical Immunology: In Practice
FDA Will Review Teva's BLA for Asthma Drug Reslizumab
Israeli Pharma gets FDA Approval for Asthma Antibody
A Guide to the PRESCRIPTION AND SERVICE REQUEST FORM FOR CINQAIR® ( reslizumab) Injection
Cinqair (reslizumab): Basics, Side Effects & Reviews
CINQAIR® (reslizumab) Injection – About Asthma Control
Clinical Outcomes and Health-Care Resource Use Associated With Reslizumab Treatment in Adults With Severe Eosinophilic Asthma in Real-World Practice - CHEST
Reslizumab – All About Drugs
Teva's Asthma Segment: What Could Boost Its Revenues in 2016?
